Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Consolidated Net Income (2021 - 2025)

PAVmed has reported Consolidated Net Income over the past 5 years, most recently at -$2.8 million for Q4 2025.

  • Quarterly results put Consolidated Net Income at -$2.8 million for Q4 2025, down 341.42% from a year ago — trailing twelve months through Dec 2025 was -$2.5 million (up 92.35% YoY), and the annual figure for FY2025 was -$2.5 million, down 108.69%.
  • Consolidated Net Income for Q4 2025 was -$2.8 million at PAVmed, up from -$6.0 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for PAVM hit a ceiling of $18.6 million in Q1 2025 and a floor of -$29.9 million in Q3 2022.
  • Median Consolidated Net Income over the past 5 years was -$17.4 million (2023), compared with a mean of -$14.4 million.
  • Peak annual rise in Consolidated Net Income hit 200.6% in 2025, while the deepest fall reached 341.42% in 2025.
  • PAVmed's Consolidated Net Income stood at -$19.7 million in 2021, then fell by 24.86% to -$24.6 million in 2022, then grew by 29.16% to -$17.4 million in 2023, then soared by 106.56% to $1.1 million in 2024, then plummeted by 341.42% to -$2.8 million in 2025.
  • The last three reported values for Consolidated Net Income were -$2.8 million (Q4 2025), -$6.0 million (Q3 2025), and -$12.3 million (Q2 2025) per Business Quant data.